Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001583648-22-000052
Filing Date
2022-06-24
Accepted
2022-06-24 19:03:46
Documents
3
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165611180914979.html 4  
1 FORM 4 wf-form4_165611180914979.xml 4 3979
2 POA (JAMES GERAGHTY HTM) pieris-section16poajames.htm EX-24 4020
3 POA (JAMES GERAGHTY JPG) pieris-section16poajames001.jpg GRAPHIC 208424
  Complete submission text file 0001583648-22-000052.txt   296676
Mailing Address C/O IDERA PHARMACEUTICALS, INC. 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
GERAGHTY JAMES A (Reporting) CIK: 0001239746 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 221041313

Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations